From Schedule I to Schedule III: The Federal Cannabis Shift
April 23, 2026
38
STATES WITH MEDICAL MJ
legal for medical use as of 2024
54
YEARS ON SCHEDULE I
since the Controlled Substances Act of 1970
~70%
280E TAX RATE BURDEN
effective tax rate on cannabis businesses under Schedule I
88%
AMERICANS SUPPORTING MEDICAL MJ
Gallup 2023 polling
$33B
U.S. CANNABIS MARKET
estimated annual legal sales, 2024
54 Years of Federal Cannabis Policy — Key Turning Points
Hover over nodes to read event details. Green nodes = high-significance turning points.
Frequently Asked Questions
DATA SOURCES
DEA Scheduling RecordsNORML State Laws DatabaseIRS Section 280E GuidanceGallup Drug Policy PollingCannabis Regulatory Association
Data sources
DEA Controlled Substances Scheduling· Drug Enforcement AdministrationControlled Substances Act of 1970 — Full Text· U.S. Congress / DEADEA Proposed Rule: Rescheduling Marijuana to Schedule III (2024)· Federal RegisterIRS Section 280E and Cannabis Businesses· Internal Revenue ServiceState Medical Marijuana Laws· National Conference of State LegislaturesGallup Cannabis Legalization Polling (1969–2023)· GallupHHS Recommendation to Reschedule Marijuana (2023)· U.S. Department of Health and Human ServicesU.S. Cannabis Market Size Estimates 2024· Cannabis Regulatory Association / MJBizDaily